The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Relationships between biochemical and symptomatic response in a double-blind randomised trial of pamidronate for metastatic bone disease
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osteoclast inhibition by pamidronate in metastatic prostate cancer: a preliminary study.
Clarke, N., Holbrook, I., McClure, J., & George, N. (1991) · British Journal of Cancer · doi:10.1038/bjc.1991.97 · Cited by 68 · cited 1×
“The presence of tumour induced osteolysis in prostate cancer explains the ability of bisphosphonates to produce symptomatic benefit in this radiographically sclerotic disease [35] as well as in patients with the classical osteolytic bone disease associated with breast cancer and multiple myeloma.”
Background
Cited by
Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity
Coleman, R. E. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0931 · Cited by 2,488
Self-citationMetastatic bone disease: clinical features, pathophysiology and treatment strategies
Coleman, R. E. (2001) · Cancer Treatment Reviews · doi:10.1053/ctrv.2000.0210 · Cited by 1,920
Self-citationSkeletal complications of malignancy
Coleman, R. E. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19971015)80:8+<1588::aid-cncr9>3.0.co;2-g · Cited by 1,502
Self-citationMacedo, F., Ladeira, K., Pinho, F., Saraiva, N., Bonito, N., Pinto, L., & Gonçalves, F. (2017) · Oncology Reviews · doi:10.4081/oncol.2017.321 · Cited by 775
Brown, J. E., Cook, R. J., Major, P., Lipton, A., Saad, F., Smith, M., Lee, K.-A., Zheng, M., Hei, Y.-J., & Coleman, R. E. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji002 · Cited by 559
Self-citationColeman, R. E., Major, P., Lipton, A., Brown, J. E., Lee, K.-A., Smith, M., Saad, F., Zheng, M., Hei, Y. J., Seaman, J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.091 · Cited by 533
Self-citationA systematic review of the role of bisphosphonates in metastatic disease
Ross, J., Saunders, Y., Edmonds, P., Patel, S., Wonderling, D., Normand, C., & Broadley, K. (2004) · Health Technology Assessment · doi:10.3310/hta8040 · Cited by 467
Bisphosphonates for the relief of pain secondary to bone metastases
Wong, R. K., & Wiffen, P. J. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002068 · Cited by 285
Lipton, A., Cook, R., Saad, F., Major, P., Garnero, P., Terpos, E., Brown, J. E., & Coleman, R. E. (2008) · Cancer · doi:10.1002/cncr.23529 · Cited by 274
Self-citation
Metadata
- Authors
- Vinholes, J. J. F., Prakash Purohit, O., Abbey, M. E., Eastell, R., & Coleman, R. E.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 1997-12
- Volume
- 8
- Issue
- 12
- Pages
- 1243-1250
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2288888750
- Cited by
- 163
- References
- 1
- FWCI
- 2.86
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.